BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.82
0.32%
US Tech 100
20,240.00
-0.65%
S&P 500
5,998.74
-0.38%
US Dollar vs CAD
1.3986
-0.16%
Bitcoin
96,241.78
0.61%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Nymox Pharmaceutical Corp (NYMX)

  7. Nymox Pharmaceutical Corp (NYMX) Financials

Nymox Pharmaceutical Corp

Nymox Pharmaceutical Corp (NYMX)

NASDAQ
0.20
0.00
(0.00%)
Closed November 29 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Nymox Pharmaceutical Corp Financial Summary

The current NYMX market cap is 18.71M. The company's latest EPS is USD -0.0945 and P/E is -2.12.

Income Statement

Annual Quarterly
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 9k0000
Operating Income -1.48M1.68M-1.39M-1.1M-1.01M
Net Income -1.49M-1.34M-1.39M-1.11M-1.04M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 116k5k000
Operating Income -13.33M-11.72M-12.5M-6.65M-8.79M
Net Income -13.16M-11.74M-12.54M-6.58M-8.84M

Balance Sheet

Annual Quarterly
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 3.14M1.63M575k271k669k
Total Liabilities 2.37M2.11M2.37M3.15M2.57M
Total Equity 773k-482k-1.8M-2.88M-1.9M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 5.49M4.34M1.44M1.63M627k
Total Liabilities 2.04M2.2M1.95M2.11M3.8M
Total Equity 3.45M2.15M-506k-482k-3.17M

Cash Flow

Annual Quarterly
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -3.96M-5.21M-988k-1.9M-3.16M
Investing N/A N/A -3k-3k-3k
Financing 5.83M5.78M-61k629k1.84M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -7.43M-10.04M-9.82M-5.21M-4.06M
Investing N/A -13k-6k N/A -3k
Financing 4.72M8.42M7.05M5.78M2.73M

Stats and Ratios

Market Cap 18.71M
Price to Earnings Ratio -2.12
Price to Sales Ratio 0
Price to Cash Ratio 285.71
Price to Book Ratio -5.9
Dividend Yield -

Share Statistics

Shares Outstanding 93.54M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.02 (7.65%)

Company Info

Company Name Nymox Pharmaceutical Corp
Address bay & deveaux sts., 2nd floor
nassau H4M 2V2
Website https://www.nymox.com
Industry chemicals & chem preps, nec (2899)
ADVFN Logo
InvestorsHub

Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canadian Securities Exchange (CSE) Level 1 and 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $738.72 only $295.49